je.st
news
Home
› Beryllium Develops An MCL-1 Platform For Structure-Guided Drug Discovery In Collaboration With The Broad Institute
Beryllium Develops An MCL-1 Platform For Structure-Guided Drug Discovery In Collaboration With The Broad Institute
2015-06-03 06:25:44| drugdiscoveryonline Home Page
Beryllium, a scientific research services company engaging in collaborations with commercial and academic partners, recently announced the development of an MCL-1 platform for structure-guided drug discovery
Tags: the
institute
drug
broad
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||